An international research team has demonstrated that a new plant-derived drug can block the progression of multiple sclerosis (MS).
University of Queensland researcher Dr Christian Gruber said the breakthrough could be a step forward in preventing and treating MS and other autoimmune diseases.
“This is a really exciting discovery because it may offer a whole new quality of life for people with this debilitating disease,” he said.
The new drug is expected to be taken by mouth, in contrast to some current MS treatments where patients need to have frequent injections.
MS is a chronic incurable condition marked by attacks that bring gradual deterioration in the patient’s health. About 23,000 people are affected in Australia and 2.5 million worldwide.
Dr Gruber said the new drug – named T20K – was extracted from a traditional medicinal plant, the Oldenlandia affinis.
The drug treatment had been successful in an animal model, and patent applications filed in several countries.
“Phase one clinical trials could begin as early as 2018,” Dr Gruber said.
“Licences have been assigned to Cyxone, a company established last year to develop this new class of drugs for the treatment of autoimmune diseases.
“Cyxone’s immediate focus is on bringing T20K through the pre-clinical program required for delivering a safe, orally active drug.”
Dr Gruber said the new treatment arose from a synthesised plant peptide, a class of drugs known as cyclotides.
“Cyclotides are present in a range of common plants, and they show significant potential for the treatment of auto immune diseases,” he said.
“The T20K peptides exhibit extraordinary stability and chemical features that are ideally what you want in an oral drug candidate.”
The international research team demonstrated in an animal model that T20K stopped progression in the normal clinical symptoms of MS.
The Latest on: Multiple sclerosis
via Google News
The Latest on: Multiple sclerosis
- Drug Shows Promise in Preventing Multiple Sclerosis Relapseson August 10, 2020 at 1:43 pm
The injectable drug ofatumamab helped reduce multiple sclerosis relapses during a recent phase III clinical trial.
- Selma Blair Says ‘I Am A Mess With MS’ As She Shares New Update On Multiple Sclerosison August 10, 2020 at 9:45 am
Actress Selma Blair has documented her battle with multiple sclerosis (MS) on Instagram ever since she was diagnosed in August 2018. She's shared everything from her treatments (i ...
- New clinical trial adds multiple sclerosis drug to boost COVID-19 patients' immune systemon August 8, 2020 at 2:29 pm
Malaria drug hydroxychloroquine fails to prevent COVID-19 in a rigorous study. This worldwide trial is aiming for 1,000 COVID-19 patients. The majority of patients will b ...
- Doctors Studying Multiple Sclerosis Drug For COVID-19 Treatmenton August 7, 2020 at 4:20 am
They are planning to combine the drug interferon beta-1a, marketed under the brand name Rebif, with remdesivir in ongoing clinical trials.
- Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 yearson August 7, 2020 at 2:14 am
To quantify the impact of focal inflammatory activity on the rate of neuro-axonal injury over the MS course. We quantified the annualized rates of change in peripapillary retinal nerve fiber layer, ...
- Multiple sclerosis drug to be studied for COVID-19 treatmenton August 6, 2020 at 12:02 pm
Large, ongoing studies of remdesivir are set to enter a new phase of research, in which doctors will test the impact of combining the drug with a medication already approved to treat multiple ...
- Drug prevents multiple sclerosis relapses in phase 3 trialon August 5, 2020 at 2:01 pm
multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most ...
- New Drug Drastically Reduces Multiple Sclerosis Symptoms In Phase III Trialon August 5, 2020 at 2:00 pm
A large-scale trial of the drug ofatumumab has found it dramatically outperforms existing treatments for relapsing-remitting multiple sclerosis (RRMS). Ind ...
- MS: First really effective treatment for multiple sclerosis could be available within five yearson August 4, 2020 at 4:07 pm
To stop multiple sclerosis from progressing we need treatments that protect nerves from damage – a goal that has proved elusive. In MS the protective coating that surrounds nerves, known as ...
- 7 Things to Ask Your Doctor After a Multiple Sclerosis Diagnosison August 3, 2020 at 8:13 am
Multiple sclerosis is a complicated disease with diverse symptoms,” Benjamin Segal, M.D., chair of the department of neurology at The Ohio State University Wexner Medical Center and co-director of ...
via Bing News